Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2020

View Archived Issues

Synthetic Biologics enters exclusive option to license intellectual property for use of SYN-020

Institut Pasteur announces advancements in the development of MV-SARS-CoV-2 vaccine

Vir Biotechnology initiates first-in-human study of VIR-3434

Discovery of selective Mdm2-inhibiting peptides maps a pathway to exploitation of the target

AhR is a therapeutic target in psoriasis

NantKwest and ImmunityBio agreement to support development COVID-19 therapeutics and vaccines

Apellis starts phase I/II study of APL-9 in severe COVID-19

FDA agrees to phase II study of OP-101 in severe COVID-19

FDA gives IND clearance for CERC-002 in COVID-19-induced ARDS

Positive interim analysis data for Auxora in patients with severe COVID-19 pneumonia

resTORbio initiates study of RTB-101 as antiviral prophylaxis to reduce severity of COVID-19

SAB Biotherapeutics plans to initiate clinical testing of potential COVID-19 therapeutic

Inhibition of Dyrk1a delays onset of amyloid and tau pathologies

Beijing FivePlus Molecular Medicine Institute patents APOC2 gene therapy

GenMont Biotech describes new probiotic compositions

NOX4 inhibition ameliorates memory deficits in Alzheimer's disease

Kallikrein-6 as novel pharmacological target to promote remyelination in multiple sclerosis

Ottawa Hospital Research Institute, United Therapeutics disclose MSCs overexpressing AOAH

Modified GLP-1 fusion proteins presented by Ajinomoto, XL-protein

STC.UNM presents antibodies targeting cholecystokinin B receptors

Positive topline data from NORA study of Zejula in Chinese patients with ovarian cancer

Initiation of Singapore study of Leukine in respiratory illness associated with COVID-19

French regulatory authorities approve the REVocan study of AsiDNA

Neurotrope and NIH launch long-term study of bryostatin in patients with AD

Metformin extends survival in mutant mCRC patients

Genmab presents positive topline data from ANDROMEDA study of daratumumab

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.